NYSE: LLYELI LILLY & Co Earnings & Revenue
LLY past earnings growth
How has LLY's earnings growth performed historically?
Company
-22.63%
Industry
10.68%
Market
82.89%
LLY's earnings have grown faster (26.12% per year) than the US Drug Manufacturers - General industry average (8.89%)
Performance
LLY's earnings have grown slower (26.12% per year) than the US market average (77.34%)
Performance
LLY's earnings growth is slowing down - its growth over the last year (-22.63%) is below its 5-year compound annual rate (26.12%)
Performance
LLY past revenue growth
How has LLY's revenue growth performed historically?
Company
5.89%
Industry
6.62%
Market
16.55%
LLY's revenue has grown slower (3.18% per year) than the US Drug Manufacturers - General industry average (4.07%)
Performance
LLY's revenue has grown slower (3.18% per year) than the US market average (15.67%)
Performance
LLY's revenue growth is accelerating - its growth over the last year (5.89%) is above its 5-year compound annual rate (3.18%)
Performance
LLY earnings and revenue history
Current Revenue
$22.9B
Current Earnings
$5.6B
Current Profit Margin
24.5%
LLY's has not demonstrated consistent long-term earnings growth over the past 10 years (53.22%)
Performance
LLY Return on equity
Current Company
170.7%
Current Industry
10.9%
Current Market
-36.3%
LLY's Return on Equity (170.7%) shows a company that is highly efficient at transforming shareholder equity into returns
Performance
LLY Return on assets
Current Company
14%
Current Industry
8.5%
Current Market
6.2%
LLY is generating higher Return on Assets (14%) than the US Drug Manufacturers - General industry average (8.27%)
Performance
LLY Return on capital employed
Current Company
21.32%
Current Industry
12.8%
LLY has gotten more efficient at generating Return on Capital (21.32%) compared to 3 years ago (10.74%)
Performance
LLY earnings dates
- Next earnings date
- Oct 27, 2020
ELI LILLY & Earnings & Revenue FAQ
What were LLY's earnings last quarter?
On Apr 23, 2020, ELI LILLY & (NYSE: LLY) reported Q1 2020 earnings per share (EPS) of $1.60, up 63.05% year over year. Total ELI LILLY & earnings for the quarter were $1.46 billion. In the same quarter last year, ELI LILLY &'s earnings per share (EPS) was $4.33.
What was LLY's revenue last quarter?
On Apr 23, 2020, ELI LILLY & (NYSE: LLY) reported Q1 2020 revenue of $5.86 billion up 15.07% year over year. In the same quarter last year, ELI LILLY &'s revenue was $5.09 billion.
What was LLY's earnings growth in the past year?
As of Q4 2020, ELI LILLY &'s earnings has grown -22.63% year over year. This is 33.31 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 10.68%. ELI LILLY &'s earnings in the past year totalled $5.62 billion.
What was LLY's revenue growth in the past year?
As of Q4 2020, ELI LILLY &'s revenue has grown 5.89% year over year. This is 0.73 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 6.62%. ELI LILLY &'s revenue in the past year totalled $22.95 billion.
What is LLY's earnings date?
ELI LILLY &'s earnings date is Oct 27, 2020. Add LLY to your watchlist to be reminded of LLY's next earnings announcement.
©2020 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
